The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Miguel Muñoz

Research Laboratory on Neuropeptides

Virgen del Rocío University Hospital

Sevilla

Spain. Electronic address:

[email]@cica.es

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Research Laboratory on Neuropeptides, Virgen del Rocío University Hospital, Sevilla, Spain. Electronic address:. 2007 - 2012
  • Hospital Infantil Universitario Virgen del Rocío, Unidad de Cuidados Intensivos Pediátricos, Av. Manuel Siurot s/n, 41013 - Sevilla. 2005 - 2012
  • Hospital Universitario Virgen del Rocío, Seville, Spain. 2004 - 2008

References

  1. The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists. Muñoz, M., González-Ortega, A., Rosso, M., Robles-Frias, M.J., Carranza, A., Salinas-Martín, M.V., Coveñas, R. Peptides (2012) [Pubmed]
  2. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011. Muñoz, M., Martinez-Armesto, J., Coveñas, R. Expert. Opin. Ther. Pat (2012) [Pubmed]
  3. NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs. Munoz, M., Covenas, R. Mini. Rev. Med. Chem (2012) [Pubmed]
  4. The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines. Muñoz, M., González-Ortega, A., Coveñas, R. Invest. New. Drugs (2012) [Pubmed]
  5. NK-1 as a melanoma target. Muñoz, M., Bernabeu-Wittel, J., Coveñas, R. Expert Opin. Ther. Targets (2011) [Pubmed]
  6. The NK-1 Receptor: A New Target in Cancer Therapy. Muñoz, M., Rosso, M., Coveñas, R. Curr. Drug. Targets (2011) [Pubmed]
  7. NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Muñoz, M., Coveñas, R. Curr. Med. Chem. (2011) [Pubmed]
  8. A new frontier in the treatment of cancer: NK-1 receptor antagonists. Muñoz, M., Rosso, M., Coveñas, R. Curr. Med. Chem. (2010) [Pubmed]
  9. Immunolocalization of NK-1 receptor and Substance P in human normal placenta. Muñoz, M., Pavón, A., Rosso, M., Salinas, M.V., Pérez, A., Carranza, A., González-Ortega, A. Placenta (2010) [Pubmed]
  10. Neurokinin-1 receptor: a new promising target in the treatment of cancer. Muñoz, M., Coveñas, R. Discov. Med (2010) [Pubmed]
  11. The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile. Muñoz, M., Rosso, M., González, A., Saenz, J., Coveñas, R. Peptides (2010) [Pubmed]
  12. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Muñoz, M., Rosso, M. Invest. New. Drugs (2010) [Pubmed]
  13. The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines. Muñoz, M., Rosso, M., Robles-Frias, M.J., Salinas-Martín, M.V., Rosso, R., González-Ortega, A., Coveñas, R. Lab. Invest. (2010) [Pubmed]
  14. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Muñoz, M., Rosso, M., Aguilar, F.J., González-Moles, M.A., Redondo, M., Esteban, F. Invest. New. Drugs (2008) [Pubmed]
  15. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Muñoz, M., Rosso, M., Coveñas, R., Montero, I., González-Moles, M.A., Robles, M.J. Invest. Ophthalmol. Vis. Sci. (2007) [Pubmed]
  16. The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Muñoz, M., Rosso, M., Pérez, A., Coveñas, R., Rosso, R., Zamarriego, C., Piruat, J.I. Neuropeptides (2005) [Pubmed]
  17. Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines. Muñoz, M., Rosso, M., Pérez, A., Coveñas, R., Rosso, R., Zamarriego, C., Soult, J.A., Montero, I. Invest. Ophthalmol. Vis. Sci. (2005) [Pubmed]
  18. Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines. Muñoz, M., Pérez, A., Rosso, M., Zamarriego, C., Rosso, R. Melanoma Res. (2004) [Pubmed]
  19. Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines. Muñoz, M., Pérez, A., Coveñas, R., Rosso, M., Castro, E. Arch. Ital. Biol (2004) [Pubmed]
 
WikiGenes - Universities